Security key
45779A846
InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR)
CUSIP: 45779A846
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 8,762,240
- Total 13F value
- $28,676,783
- Share change
- +707,989
- SEC-reported price per share
- $3.27
- Number of holders
- 25
- Value change
- +$2,327,230
- Number of buys
- 10
- Number of sells
- 3
- Shares outstanding
- 48,244,715
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
25
Top holders
10
NSPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
InspireMD, Inc. SEC filings
InspireMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45779A846
Recent filing periods:
Ownership snapshot
Top reported holders of NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MARSHALL WACE, LLP
Disclosed value leader
MARSHALL WACE, LLP
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 3.9%
Showing 1-6 of 15 holder rows.
Quick read
MARSHALL WACE, LLP leads the comparable SEC ownership view at 3.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MARSHALL WACE, LLP's linked filing trail.
Comparable ownership
Top 5
MARSHALL WACE, LLP
3.9%
Nantahala Capital Management, LLC
3.9%
ORBIMED ADVISORS LLC
3.9%
Soleus Capital Management, L.P.
2.9%
Velan Capital Investment Manageme...
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP |
13F
Company
|
3.9%
|
$4,669,617
1,860,405 shares
|
— | 30 Jun 2023 |
| Nantahala Capital Management, LLC |
13F
Company
|
3.9%
|
$4,669,617
1,860,405 shares
|
— | 30 Jun 2023 |
| ORBIMED ADVISORS LLC |
13F
Company
|
3.9%
|
$4,669,617
1,860,405 shares
|
— | 30 Jun 2023 |
| Soleus Capital Management, L.P. |
13F
Company
|
2.9%
|
$3,459,101
1,378,128 shares
|
— | 30 Jun 2023 |
| Velan Capital Investment Management LP |
13F
Company
|
1.9%
|
$2,269,113
904,029 shares
|
— | 30 Jun 2023 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
0.12%
|
$139,757
55,680 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
8,762,240
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
22
Q3 2023 holders
25
Holder diff
3
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend